Detalles de la búsqueda
1.
Clinical relevance of clonal hematopoiesis in persons aged ≥80 years.
Blood
; 138(21): 2093-2105, 2021 11 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-34125889
2.
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with lower risk myelodysplastic syndromes with ring sideroblasts.
Am J Hematol
; 98(8): E204-E208, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37222267
3.
Driver somatic mutations identify distinct disease entities within myeloid neoplasms with myelodysplasia.
Blood
; 124(9): 1513-21, 2014 Aug 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-24970933
4.
Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1.
Haematologica
; 98(3): 420-3, 2013 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23300182
5.
CSF3R-mutant chronic myelomonocytic leukemia is a distinct clinically subset with abysmal prognosis: a case report and systematic review of the literature.
Leuk Lymphoma
; 64(9): 1566-1573, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37395413
6.
Synthetic Data Generation by Artificial Intelligence to Accelerate Research and Precision Medicine in Hematology.
JCO Clin Cancer Inform
; 7: e2300021, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37390377
7.
Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes.
J Clin Oncol
; 41(15): 2827-2842, 2023 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36930857
8.
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis.
Blood Adv
; 6(6): 1855-1864, 2022 03 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130339
9.
PBX1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm.
Stem Cell Reports
; 16(11): 2607-2616, 2021 11 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34678207
10.
Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes.
J Clin Oncol
; 39(11): 1223-1233, 2021 04 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33539200
11.
Costimulatory Molecules and Immune Checkpoints Are Differentially Expressed on Different Subsets of Dendritic Cells.
Front Immunol
; 10: 1325, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31244860
12.
Clinical evaluation of extra-hematologic comorbidity in myelodysplastic syndromes: ready-to-wear versus made-to-measure tool.
Haematologica
; 97(4): 631-2, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22271887
13.
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda".
Leuk Res
; 42: 21-7, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26852003
14.
Platelet count predicts driver mutations' co-occurrence in low JAK2 mutated essential thrombocythemia and myelofibrosis.
Leukemia
; 35(5): 1490-1493, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33051550
15.
Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.
J Clin Oncol
; 34(30): 3627-3637, 2016 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-27601546
16.
Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda".
Leuk Res
; 37(10): 1233-40, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23906627
Resultados
1 -
16
de 16
1
Próxima >
>>